Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Pulmonary Safety of Staccato Alprazolam in Healthy and Mild Asthma Participants
NCT04802746Phase 1Completed
- Sponsor
- UCB
- Start
- Mar 2021
- Primary completion
- Nov 2021
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 1, randomised, double-blind trial of alprazolam in epilepsy (8 arms), sponsored by UCB. Primary endpoints: Change from Baseline in Forced Expiratory Volume in 1 second (FEV1) and Percentage of study participants with respiratory treatment-emergent adverse events. Started Mar 2021; status: completed.
02
Drugs
alprazolam
03
Conditions
epilepsy
Beyond the preview
Go deeper on NCT04802746.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04802746.